Détail de l'auteur
Documents disponibles écrits par cet auteur (21)
trié(s) par (Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) | Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de recherche
Article
Mendes-da-Cruz DA ; Lemos JP ; Belorio EP ; Savino W | 2025
Article
Lemos JP ; Tenório LPG ; Mouly V ; Butler-Browne G ; Mendes-da-Cruz DA ; Savino W ; Smeriglio P | 18/10/2023
Article
Bonomo AC ; Pinto-Mariz F ; Riederer I ; Benjamim CF ; Butler-Browne G ; Mouly V ; Savino W | 2020
Article
Ladislau L, Auteur ; Portilho DM ; Courau T ; Solares-Pérez A ; Negroni E ; Laine J ; Klatzmann D ; Bonomo A ; Allenbach Y ; Benveniste O ; Riederer I ; Savino W ; Mouly V ; Butler Browne G ; Benjamim CF | 01/05/2018Correction: Activated dendritic cells modulate proliferation and differentiation of human myoblasts. Cell Death Dis. 2022 Sep 22;13(9):811. Correction to: Cell Death and Disease 10.1038/s41419-018-0426-z, published online 10 May 2018 "The ori[...]
Article
Savino W, Auteur ; Pinto-Mariz F ; Mouly V | 2018
Article
Portilho DM ; Alves MR ; Kratassiouk G ; Roche S ; Magdinier F ; de Santana EC ; Polesskaya A ; Harel-Bellan A ; Mouly V ; Savino W ; Butler Browne G ; Dumonceaux J | 2015
Article
Pinto-Mariz F, Auteur ; Rodrigues Carvalho L ; Prufer de Queiroz Campos Araujo A ; de Mello W ; Gonçalves Ribeiro M ; Cunha Mdo C ; Cabello PH ; Riederer I ; Negroni E ; Desguerre I ; Veras M ; Yada E ; Allenbach Y ; Benveniste O ; Voit T ; Mouly V ; Silva-Barbosa SD ; Butler Browne G ; Savino W | 2015
Article
Barthelemy I ; Pinto-Mariz F ; Yada E ; Desquilbet L ; Savino W ; Silva-Barbosa SD ; Faussat AM ; Mouly V ; Voit T ; Blot S ; Butler Browne G | 2014Comment in: Early loss of ambulation is not a representative clinical feature in Duchenne muscular dystrophy dogs: remarks on the article of Barthélémy et al. Duan D, Hakim CH, Ambrosio CE, Smith BF, Sweeney HL. Dis Model Mech. 2015 Ma[...]
Article
Portilho DM ; Soares CP ; Morrot A ; Thiago LS ; Butler Browne G ; Savino W ; Costa ML ; Mermelstein C | 2012
Article
Riederer I ; Negroni E ; Bencze M ; Wolff A ; Aamiri A ; Silva-Barbosa SD ; Butler Browne G ; Savino W ; Mouly V | 2012Accès au résumé PubMed / to PubMed abstract
Article
Bencze M ; Negroni E ; Vallese D ; Yacoub-Youssef H ; Chaouch S ; Wolff A ; Aamiri A ; Di Santo JP ; Chazaud B ; Butler Browne G ; Savino W ; Mouly V ; Riederer I | 2012
Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Pinto Mariz F ; Carvalho L ; Araujo A ; de Mello W ; Ribeiro M ; Cunha MDC ; Riederer I ; Negroni E ; Mouly V ; Voit T ; Desguerre I ; Butler Browne G ; Savino W ; Silva-Barbosa SD | 2011Background. Duchenne muscular dystrophy (DMD) affects 1:3,500 male births, and is caused by mutations in the dystrophin gene. Even though the genetic mutation results in decreased resistance of muscle fibers, the immune response may contribute t[...]
Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Portilho D ; Mendes F ; Costa M ; Butler Browne G ; Garcia J ; Savino W ; Mermelstein C | AFM-TELETHON | 2011Skeletal muscle differentiation is a multi-step process that begins with the commitment of mononucleated precursors that withdraw from cell cycle. These myoblasts elongate while aligning to each other, guided by the recognition between their mem[...]
Article
Pinto-Mariz F ; Negroni E ; Barthelemy I ; Blot S ; Savino W ; Voit T ; Mouly V ; Butler-Browne GS | 2011Duchenne muscular dystrophy (DMD) is an X-linked muscle wasting disease caused by the absence of functional dystrophin at the sarcolemma. There is currently no therapy for this disease, but stem cell-based cell therapy, eventually in combination[...]
Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Bencze M ; Negroni E ; Yacoub-Youssef H ; Chaouch S ; Wolff A ; Di Santo J ; Chazaud B ; Butler-Browne GS ; Savino W ; Mouly V ; Riederer I | 2011Cell therapy has been envisaged for some genetic muscular disorders using myoblasts in order to deliver the missing protein. Although pre-clinical trials in the mouse were promising, therapeutic trials using local injection of myoblasts failed t[...]
Article
4th International Congress of Myology, 4ème colloque international de Myologie (9-13 mai 2011; Lille (France)) ; Pinto Mariz F ; Barthelemy I ; Yada E ; Voit T ; Silva-Barbosa SD ; Savino W ; Butler Browne G ; Blot S | 2011It is well known that the disease course in Duchenne muscular dystrophy (DMD) patients is heterogeneous, varying from patient to patient. Such heterogeneity is also seen in the Golden Retriever Muscular Dystrophy (GRMD) dogs. This is a drawback [...]
Article
Pinto-Mariz F ; Rodrigues Carvalho L ; de Mello W ; de Queiroz Campos Araujo A ; Gonçalves Ribeiro M ; do Carmo Soares Alves Cunha M ; Voit T ; Butler Browne G ; Silva-Barbosa SD ; Savino W | 2010Accès au résumé Pubmed/to pubmed abstract
Article
Congrès international de myologie 2008 (International Congress of Myology 2008; 26-30 mai 2008; Marseille, France) ; Riederer I ; Negroni E ; Bencze M ; Wolff A ; Savino W ; Butler-Browne GS ; Silva-Barbosa S ; Mouly V | 2008Myoblast transplant therapy (MTT) can be envisioned as a clinical alternative in the treatment of certain diseases. The problems that still remain to be solved to improve the efficiency of MTT are the massive early cell death, the limited prolif[...]
Article
Silva-Barbosa SD ; Butler-Browne GS ; de Mello W ; Riederer I ; Savino W ; Mouly V | 2008Accès au résumé PubMed / to PubMed abstract
Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Riederer I ; Negroni E ; Bencze M ; Savino W ; Mouly V ; Silva-Barbosa SD ; Butler-Browne GS | 2005Communication n° 501 Myoblast transplant therapy (MTT) can be envisioned as a clinical alternative in the treatment of several myopathies. The problems that remain to be solved to improve the efficiency of MTT is the massive early death of trans[...]
Article
Congrès international de myologie 2005 (International Congress of Myology 2005; 9-13 mai 2005; Nantes, France) ; Riederer I ; Negroni El ; Savino W ; Bencze M ; Mouly V ; Silva-Barbosa SD ; Butler-Browne GS | 2005Communication n° 495 Myoblast transplant therapy (MTT) can be envisioned as a clinical alternative in the treatment of several myopathies. The problems that remain to be solved to improve the efficiency of MTT is the massive early death of trans[...]
